🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great to see women who were trained to do HIIT and TRE were more likely to follow this protocol over 2 years. TRE+HIIT sustained muscle mass, and reduced abdominal fat. nature.com/articles/s4159…

I have been attending on the inpatient cardiology consult service for 15 years UC San Diego Health and very few things surprise me. Today I was consulting on a patient on the plastic surgery service and in the medication list it had “leech bug q4” and the progress note said “keep

New study JACC Journals of Lp(a) and subclinical atherosclerosis in 2.9 million Chinese individuals - Elevated Lp(a) a/w increased CIMT, carotid plaque, CAC - Elevated Lp(a) a/w more widespread subclinical atherosclerosis involving multiple sites jacc.org/doi/10.1016/j.…

Congrats to Elizabeth Sage Epstein, MD for leading this article where we discuss hormesis which is the concept of exposing the body to small doses of intermittent stress to activate biochemical and molecular pathways that evolved to sustain living things through hardship. Hormesis is the

⁦Borge G Nordestgaard⁩ giving an outstanding talk at ⁦the joint European Atherosclerosis Society⁩ and @nla at #EAS2025 on remnant cholesterol. ⁦Christie Ballantyne⁩ ⁦Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦⁩ ⁦Taher Modarressi, M.D. ⁦Jamal Rana, MD⁩ ⁦Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦⁩ ⁦⁦Prof Kausik Ray FMedSci⁩

Great overview by ⁦Christie Ballantyne⁩ at the joint ⁦National Lipid Association⁩ ⁦European Atherosclerosis Society⁩ session.⁦Prof Kausik Ray FMedSci⁩ ⁦Borge G Nordestgaard⁩ ⁦Jamal Rana, MD⁩ ⁦Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦⁩ ⁦Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦⁩ ⁦Raul Santos⁩ ⁦Pablo Corral MD⁩

#EASCongress2025 Late Breakers - Key takeaway in one line! #MyEAS2025 Check out the slide below for a one-line summary of each late-breaking presentation — concise, clear, and all in one place 😎 EAS Congress European Atherosclerosis Society

⁦Pam R. Taub, MD❤️💃🏻⁩ excellent presentation on role of Inclisiran monotherpy. ⁦JACC Journals⁩ ⁦Borge G Nordestgaard⁩ ⁦Prof Kausik Ray FMedSci⁩ ⁦EAS Congress⁩ #EAS2025

Prof Kausik Ray FMedSci EAS Congress European Atherosclerosis Society Pablo Corral MD Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦 Dr Meral Kayikcioglu Could not agree more Prof Kausik Ray FMedSci ! ❤️EAS Congress Borge G Nordestgaard Pam R. Taub, MD❤️💃🏻 SABOURETCardiologist Rohan Khera Christie Ballantyne Pablo Corral MD Federica Fogacci Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦 Michael D. Shapiro Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 John Kastelein Dr Meral Kayikcioglu Marta Kaluzna-Oleksy #EASCongress2025

Michael Wilkinson National Lipid Association Foundation of the NLA Christie Ballantyne Marlys Koschinsky Pam R. Taub, MD❤️💃🏻 Harpreet Bhatia UC San Diego Cardiology UC San Diego Health Michael D. Shapiro Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 For those not able to join us but who are interested in the presentation, it is available to view here: lipid.org/practicalpearls

JACC STATE-OF-THE-ART REVIEW: do you have problems understanding all the new drugs to lower triglycerides and remnant cholesterol: lipid and side effects, target populations, approved or not by FDA+EMA? Ask Tybjærg Nordestgaard et al explain the details authors.elsevier.com/a/1l4pB2d9GI27…

Congrats to my mentee Cameron Ormiston who has been working with me since he was a freshman at UC San Diego and is now a medical student at Mount Sinai Health System for leading this article. We showed in this proof-of-concept study that pure epicatechin capsules (epicatechin is present in

Finerenone reduces CKD progression & CVD in T2D (FIDELIO/FIGARO), driven by ↓ HF hospitalizations. FINEARTS-HF shows benefit in HFmrEF/HFpEF. More to come from MOONRAKER in HF irrespective of EF (link.springer.com/article/10.100…). #HREV Pam R. Taub, MD❤️💃🏻 Steve Greene Marat Fudim, MD MHS Andrew J Sauer MD

Honored to moderate this Medscape theheartorg | Medscape CME with D. Rader & Pam R. Taub, MD❤️💃🏻 on new exciting strategies to improve the lives of pts with familial chylomicronemia syndrome medscape.org/viewarticle/da…

#HID2025 Superb talk by Pam R. Taub, MD❤️💃🏻 at Heart in Diabetes 🫀 on lipid management in women across life course. ➡️ Lp(a) rises in menopause. Recheck level if previously borderline. ➡️Bempedoic acid a good option in statin intol. ➡️ Optimize CV risk factors before menopause. TMIOA 🧬

NEW #RCParallax by Ankur Kalra Ep 136 🎙️This week's guest is Dr Pam R. Taub, MD❤️💃🏻 who joins for an enlightening conversation about integrating spirituality, purpose, and scientific curiosity in cardiovascular practice. 🎧 Listen Now 👉 ow.ly/rF0n50W6gvh #CardioEd #MedEd

Happy birthday to the UC San Diego Cardiology legend of Atrial Flutter ablation and rock and roll, Dr. Feld!

Why should you test for Lp(a)? #KnowLpa Family Heart Foundation ASPC UC San Diego Cardiology UC San Diego Cardiology Fellows

We are excited to announce the launch of the UC San Diego BEACON (Bioinformatics, Epidemiology, and Lp(a) Center for Research and InnOvatioN), in the Division of Cardiovascular Medicine: lpa.ucsd.edu We look forward to collaborating with our colleagues across the

➡️In Journal of Clinical Lipidology: real-world data, early experience with inclisiran UC San Diego Health UC San Diego Cardiology Congrats Donya Mazdeyasnan, Antoinette Birs, MD, Tommy Chiou Pam R. Taub, MD❤️💃🏻 ASPC Christie Ballantyne Michael D. Shapiro Taher Modarressi, M.D. Archna Bajaj Nishant Shah, MD sciencedirect.com/science/articl…